(14971513), A. O., (14971516), R. C., (14971519), G. v. A., (14971522), C. R., (14971525), S. F., (14971528), W. L., . . . (14971558), M. J. (2025). Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cita Chicago Style (17a ed.)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.
Cita MLA (9a ed.)(14971513), Aurelius Omlin, et al. Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer. 2025.